Compare ARK Genomic Revolution ETF (ARKG) vs iShares Core MSCI Emerging Markets ETF (IEMG) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
ARK Genomic Revolution ETF vs iShares Core MSCI Emerging Markets ETF — how do they compare? ARK Genomic Revolution ETF trades at $41.21, while iShares Core MSCI Emerging Markets ETF trades at $79.32. The key difference: ARK Genomic Revolution ETF is trading nearer its 52-week high, iShares Core MSCI Emerging Markets ETF nearer its low. Which is the better fit depends on your goals.
| ARKG | IEMG | |
|---|---|---|
Sector | Sector/Thematic | Broad Market / Factor |
52-Week High | $43.57 | $86.00 |
52-Week Low | $23.09 | $59.90 |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ARKG trades at $41.32, down 3.91% today, with a bullish technical signal driven by moving averages. Recent news highlights biotech ETF strength in June 2026, fueled by strong earnings, M&A activity, and AI-driven drug discovery optimism. Key support lies at $40, with resistance at $44.
The outlook remains positive given sector tailwinds, but risks include regulatory hurdles and market volatility. Investor sentiment is buoyed by industry growth catalysts, though selective investment approaches are noted by analysts.
IEMG trades at $81.33, up 0.38% today, but technical indicators signal a bearish trend with moving averages and ADX pointing lower. The ETF has surged 35% over the past year, driven by strong inflows into emerging markets and a 40% technology weighting, particularly in South Korean and Taiwanese AI-related stocks. Recent news highlights record capital flows and outperformance versus developed markets, though volatility remains elevated.
Outlook is mixed: attractive valuations and AI exposure offer growth potential, but concentration risk and geopolitical tensions pose headwinds. Investors face trade-offs between higher returns and increased volatility, with analyst sentiment cautious due to recent price gains.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About ARK Genomic Revolution ETF
ARKG is an actively managed ETF that invests in the genomic revolution. It focuses on companies leading in gene editing, CRISPR technology, therapeutics, and molecular diagnostics, including firms like CRISPR Therapeutics and Tempus AI.
Read more on ARKG →About iShares Core MSCI Emerging Markets ETF
IEMG tracks the MSCI Emerging Markets Investable Market Index, providing broad exposure to large, mid, and small-cap stocks across over 20 emerging market countries. It is designed as a low-cost core holding for investors seeking diversified growth from economies outside of developed markets.
Read more on IEMG →
